227. Osler disease Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 56 / Drugs : 72 - (DrugBank : 21) / Drug target genes : 23 - Drug target pathways : 136
Osler disease and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 227 | Osler disease | - |
| 85 | Idiopathic interstitial pneumonia | 16.330 |
| 228 | Bronchiolitis obliterans | 13.491 |
| 51 | Scleroderma | 10.475 |
| 46 | Malignant rheumatoid arthritis | 8.936 |
| 13 | Multiple sclerosis/Neuromyelitis optica | 8.810 |
| 28 | Systemic amyloidosis | 8.461 |
| 89 | Lymphangioleiomyomatosis | 7.599 |
| 151 | Rasmussen encephalitis | 6.000 |
| 96 | Crohn disease | 5.637 |
| 226 | Interstitial cystitis with Hunners ulcer | 5.231 |
| 39 | Toxic epidermal necrolysis | 5.229 |
| 302 | Leber hereditary optic neuropathy | 5.000 |
| 6 | Parkinson disease | 4.648 |
| 53 | Sjogren syndrome | 4.418 |
| 38 | Stevens-Johnson syndrome | 4.403 |
| 113 | Muscular dystrophy | 4.357 |
| 65 | Primary immunodeficiency | 4.070 |
| 299 | Cystic fibrosis | 4.035 |
| 86 | Pulmonary arterial hypertension | 4.015 |
| 158 | Tuberous sclerosis | 3.975 |
| 49 | Systemic lupus erythematosus | 3.954 |
| 2 | Amyotrophic lateral sclerosis | 3.808 |
| 55 | Relapsing polychondritis | 3.783 |
| 11 | Myasthenia gravis | 3.710 |
| 58 | Hypertrophic cardiomyopathy | 3.652 |
| 286 | Hereditary sideroblastic anemia | 3.533 |
| 269 | Pyogenic arthritis | 3.339 |
| 285 | Fanconi anemia | 3.267 |
| 34 | Neurofibromatosis | 3.262 |
| 64 | Thrombotic thrombocytopenic purpura | 3.228 |
| 41 | Giant cell arteritis | 3.163 |
| 162 | Pemphigoid | 3.163 |
| 164 | Oculocutaneous albinism | 3.133 |
| 45 | Eosinophilic granulomatosis with Polyangiitis | 3.043 |
| 160 | Congenital ichthyosis | 3.043 |
| 95 | Autoimmune hepatitis | 2.966 |
| 60 | Aplastic anemia | 2.942 |
| 50 | Dermatomyositis | 2.841 |
| 284 | Diamond-Blackfan anemia | 2.775 |
| 20 | Adrenoleukodystrophy | 2.775 |
| 234 | Peroxisomal disease (except Adrenoleukodystrophy) | 2.717 |
| 222 | Primary nephrotic syndrome | 2.689 |
| 40 | Takayasu arteritis | 2.630 |
| 42 | Polyarteritis nodosa | 2.589 |
| 274 | Osteogenesis Imperfecta | 2.484 |
| 224 | Purpura nephritis | 2.391 |
| 326 | Osteopetrosis | 2.310 |
| 56 | Behcet disease | 2.304 |
| 26 | HTLV-1-associated myelopathy | 2.265 |
| 283 | Acquired pure red cell aplasia | 2.174 |
| 63 | Idiopathic thrombocytopenic purpura | 2.157 |
| 36 | Epidermolysis bullosa | 2.108 |
| 90 | Retinitis pigmentosa | 2.108 |
| 107 | Juvenile idiopathic arthritis | 2.077 |
| 62 | Paroxysmal nocturnal hemoglobinuria | 2.019 |
| 276 | Achondroplasia | 1.957 |
| 278 | Huge lymphatic malformation with cervicofacial lesion | 1.957 |
| 19 | Lysosomal storage disease | 1.951 |
| 61 | Autoimmune hemolytic anemia | 1.870 |
| 97 | Ulcerative colitis | 1.751 |
| 93 | Primary biliary cholangitis | 1.646 |
| 66 | IgA nephropathy | 1.646 |
| 215 | Tetralogy of Fallot | 1.430 |
| 169 | Menkes disease | 1.261 |
| 170 | Occipital horn syndrome | 1.261 |
| 167 | Marfan syndrome | 1.174 |
| 87 | Pulmonary veno-occlusive disease | 1.087 |
| 67 | Polycystic kidney disease | 1.043 |
| 111 | Congenital myopathy | 1.000 |